Key facts
- Waypoint Orthopedics’s last known valuation is $300K (Jan 2020).
- It has raised $4.0M across 5 recorded rounds; the latest was Seed Round ($300K) in Mar 2026.
- Notable investors include Alere Financial Partners, Runway Healthcare.
- Waypoint Orthopedics has filed 9 Form Ds with the SEC since 2020, most recently Sep 2025 ($50K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Waypoint Orthopedics
Funding rounds
5 roundsAbout Waypoint Orthopedics
Developer of surgical devices designed to make vertebral fixation safer and more efficient. The company's product provides physicians with real-time visual feedback on the location of the cutting edge of the probe, enabling medical practitioners to identify the probe's location in the pedicle as they advance it, thereby avoiding cortical breaches and reducing the radiation required during traditional surgery.
- Sector
- Healthcare
- HQ
- Malvern, PA, United States
- Founded
- 2020
- Employees
- 2
- Website
- waypointorthopedics.com/
- Ownership
- Privately Held (backing)
Waypoint Orthopedics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Waypoint Orthopedics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Waypoint Orthopedics in its N-PORT filings yet. We sweep new filings monthly.